Xiangjun Qiu

581 total citations
48 papers, 447 citations indexed

About

Xiangjun Qiu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Xiangjun Qiu has authored 48 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Pharmacology. Recurrent topics in Xiangjun Qiu's work include Analytical Methods in Pharmaceuticals (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Xiangjun Qiu is often cited by papers focused on Analytical Methods in Pharmaceuticals (9 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Xiangjun Qiu collaborates with scholars based in China, Czechia and Pakistan. Xiangjun Qiu's co-authors include Ren-ai Xu, Guoxin Hu, Jingjing Chen, Guanyang Lin, Yuanyuan Shao, Yongliang Zhu, Lei Ye, Jianlong Zhao, Bing Wang and Zhe Wang and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Food Chemistry.

In The Last Decade

Xiangjun Qiu

48 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangjun Qiu China 11 150 95 75 61 60 48 447
Honggang Lou China 11 109 0.7× 99 1.0× 73 1.0× 49 0.8× 16 0.3× 60 467
Suresh P. Sulochana India 13 170 1.1× 66 0.7× 89 1.2× 42 0.7× 41 0.7× 60 472
Sanjeev Giri India 11 122 0.8× 45 0.5× 50 0.7× 29 0.5× 13 0.2× 35 287
Fen Wei China 14 205 1.4× 88 0.9× 52 0.7× 68 1.1× 13 0.2× 26 426
Damien Richard France 11 115 0.8× 18 0.2× 59 0.8× 29 0.5× 43 0.7× 14 356
Guo Ma China 15 223 1.5× 17 0.2× 87 1.2× 122 2.0× 15 0.3× 53 602
Noriko Daneshtalab Canada 12 74 0.5× 64 0.7× 37 0.5× 20 0.3× 14 0.2× 20 363
Rebecca L. Oberle United States 7 68 0.5× 64 0.7× 81 1.1× 86 1.4× 12 0.2× 9 472
Amitava Dasgupta United States 12 184 1.2× 30 0.3× 60 0.8× 80 1.3× 10 0.2× 43 492
Kohji Naora Japan 13 142 0.9× 45 0.5× 194 2.6× 93 1.5× 9 0.1× 56 553

Countries citing papers authored by Xiangjun Qiu

Since Specialization
Citations

This map shows the geographic impact of Xiangjun Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjun Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjun Qiu more than expected).

Fields of papers citing papers by Xiangjun Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjun Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjun Qiu. The network helps show where Xiangjun Qiu may publish in the future.

Co-authorship network of co-authors of Xiangjun Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjun Qiu. A scholar is included among the top collaborators of Xiangjun Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjun Qiu. Xiangjun Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Li, Xiaoli Wan, Handong Wang, et al.. (2025). Fe3O4@Ag@Pt nanoparticles with multienzyme like activity for total antioxidant capacity assay. Food Chemistry. 473. 143064–143064. 8 indexed citations
2.
3.
Wang, Yingfei, et al.. (2024). Serum untargeted metabolomics analysis of mice after myocardial infarction affected by qiliqiangxin capsule. Journal of Pharmaceutical and Biomedical Analysis. 252. 116516–116516. 3 indexed citations
4.
Xu, Jiachen, et al.. (2024). Serum untargeted metabolomics analysis of the preventive mechanism of TAETEA Prebiotea on non-alcoholic fatty liver in rats. Journal of Pharmaceutical and Biomedical Analysis. 247. 116218–116218. 3 indexed citations
5.
Wei, Xinyi, et al.. (2023). Exploring the Effect of Compound Glycyrrhizin and Silybinin on the Metabolism of Pexidartinib in Rats Based on CYP3A4 and CYP2C9. Advances in Pharmacological and Pharmaceutical Sciences. 2023. 1–8. 2 indexed citations
6.
Qiu, Xiangjun, et al.. (2022). Validated UPLC-MS/MS Method for Determination of Futibatinib and Its Pharmacokinetics in Beagle Dogs. Journal of Chemistry. 2022. 1–7. 4 indexed citations
7.
Li, Heng, et al.. (2022). Pharmacokinetics of Herb-Drug Interactions of Plumbagin and Tazemetostat in Rats by UPLC-MS/MS. Drug Design Development and Therapy. Volume 16. 3385–3394. 3 indexed citations
8.
Sun, Bo, et al.. (2021). Effect of Sijunzi Pills on Pharmacokinetics of Omeprazole in Beagle Dogs by HPLC-UV: A Herb-Drug Interaction Study. Evidence-based Complementary and Alternative Medicine. 2021. 1–6. 3 indexed citations
9.
Wang, Huijun, et al.. (2021). The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique. Drug Design Development and Therapy. Volume 15. 4865–4873. 10 indexed citations
10.
Zhang, Jiahui, et al.. (2021). UPLC‐MS/MS for the Herb‐Drug Interactions of Xiao‐Ai‐Ping Injection on Enasidenib in Rats Based on Pharmacokinetics. BioMed Research International. 2021(1). 6636266–6636266. 5 indexed citations
11.
Hu, Jie, et al.. (2021). Simultaneous Determination of Celecoxib, Dezocine and Dexmedetomidine in Beagle Plasma Using UPLC-MS/MS Method and the Application in Pharmacokinetics. Drug Design Development and Therapy. Volume 15. 2529–2541. 7 indexed citations
12.
Hu, Jie, et al.. (2020). Effects of Dexmedetomidine on the Pharmacokinetics of Parecoxib and Its Metabolite Valdecoxib in Beagles by UPLC‐MS/MS. BioMed Research International. 2020(1). 1563874–1563874. 6 indexed citations
13.
Zhu, Yongliang, et al.. (2020). Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS). Journal of Ethnopharmacology. 260. 112832–112832. 36 indexed citations
14.
Qiu, Xiangjun, et al.. (2019). <p>Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study</p>. Drug Design Development and Therapy. Volume 13. 2865–2871. 8 indexed citations
15.
Zeng-shou, Wang, Liping Yang, Da‐Peng Dai, et al.. (2015). In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population. Drug Metabolism and Disposition. 43(4). 561–569. 12 indexed citations
16.
Qiu, Xiangjun, et al.. (2015). Simultaneous determination of acetaminophen and dihydrocodeine in human plasma by UPLC–MS/MS: Its pharmacokinetic application. Journal of Chromatography B. 992. 91–95. 17 indexed citations
17.
Wang, Zhe, Hui Yang, Wei Sun, et al.. (2014). UPLC–MS/MS determination of thiamphenicol in human plasma and its application to a pharmacokinetic study. Journal of Chromatography B. 967. 235–239. 7 indexed citations
18.
Wang, Chenming, et al.. (2013). Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat. Drug Development and Industrial Pharmacy. 40(12). 1616–1622. 21 indexed citations
19.
Liu, Hu, Minjie Wu, Yi Zhang, et al.. (2012). [Wound information management system: a standardized scheme for acquisition, storage and management of wound information].. PubMed. 28(3). 197–200. 1 indexed citations
20.
Qiu, Xiangjun, et al.. (2012). Determination of Pantoprazole in Rat Plasma by LC-MS/MS and its Application to Pharmacokinetics. Latin American Journal of Pharmacy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Honggang Lou Breakdown of academic impact, for papers by Suresh P. Sulochana Breakdown of academic impact, for papers by Sanjeev Giri Breakdown of academic impact, for papers by Fen Wei Breakdown of academic impact, for papers by Damien Richard Breakdown of academic impact, for papers by Guo Ma Breakdown of academic impact, for papers by Noriko Daneshtalab Breakdown of academic impact, for papers by Rebecca L. Oberle Breakdown of academic impact, for papers by Amitava Dasgupta Breakdown of academic impact, for papers by Kohji Naora
Rankless by CCL
2026